Unveiling the influence of tumor and immune signatures on immune checkpoint therapy in advanced lung cancer.
Kim N, Park S, Jo A, Eum HH, Kim HK, Lee K, Cho JH, Ku BM, Jung HA, Sun JM, Lee SH, Ahn JS, Lee JI, Choi JW, Jeong D, Na M, Kang H, Kim JY, Choi JK, Lee HO, Ahn MJ.
Kim N, et al. Among authors: cho jh.
Elife. 2024 Nov 8;13:RP98366. doi: 10.7554/eLife.98366.
Elife. 2024.
PMID: 39514276
Free PMC article.